听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览Future Microbiology期刊下所有文献
  • Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.

    abstract::Retapamulin is a semisynthetic pleuromutilin compound with in vitroactivity against Gram-positive bacteria, no cross-resistance to other classes of antimicrobial agents in current use and a low potential for development of resistance. A 1% ointment formulation has been developed for clinical use, and a placebo-control...

    journal_title:Future microbiology

    pub_type: 临床试验,杂志文章

    doi:10.2217/17460913.2.6.591

    authors: Jacobs MR

    更新日期:2007-12-01 00:00:00

  • Combination antifungal therapy: the new frontier.

    abstract::The past decade has seen a significant increase in the incidence of invasive fungal infections. The antifungal armamentarium for the treatment of serious fungal infections remains limited. A possible approach to overcoming antifungal drug resistance and high mortality rates seen in severe fungal infections is to combi...

    journal_title:Future microbiology

    pub_type: 杂志文章,评审

    doi:10.2217/17460913.2.2.115

    authors: Vazquez JA

    更新日期:2007-04-01 00:00:00

  • Nanoscale exploration of microbial surfaces using the atomic force microscope.

    abstract::Atomic force microscopy (AFM) has recently opened a variety of novel possibilities for imaging and manipulating microbial surfaces in their native environment. While AFM imaging offers a means to visualize surface structures at high resolution and in physiological conditions, AFM force spectroscopy enables researchers...

    journal_title:Future microbiology

    pub_type: 杂志文章,评审

    doi:10.2217/17460913.1.4.387

    authors: Dufrêne YF

    更新日期:2006-12-01 00:00:00

  • Controversies in the treatment of pneumococcal community-acquired pneumonia.

    abstract::Community-acquired pneumonia remains an important cause of disease and death both in the developed and the developing worlds, despite the ready availability of potent antimicrobial agents to which the organisms remain susceptible. Furthermore, disease management is complicated by emerging resistance of the common path...

    journal_title:Future microbiology

    pub_type: 杂志文章,评审

    doi:10.2217/17460913.1.3.271

    authors: Feldman C,Anderson R

    更新日期:2006-10-01 00:00:00

  • Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.

    abstract::Micafungin is a new drug in the echinocandin class and is currently being investigated in Phase III clinical trials. Like other echinocandins, it inhibits 1,3-beta-D-glucan synthesis, thus achieving fungicidal activity against virtually all Candida spp., including those resistant to fluconazole, and fungistatic activi...

    journal_title:Future microbiology

    pub_type: 杂志文章,评审

    doi:10.2217/17460913.1.2.161

    authors: Vehreschild JJ,Cornely OA

    更新日期:2006-08-01 00:00:00

  • Folate metabolism as a source of molecular targets for antimalarials.

    abstract::Folate metabolism of the malaria parasites provides two targets for current antimalarials: dihydrofolate reductase and dihydropteroate synthase. Dihydrofolate reductase inhibitors have been used as antimalarials over the past few decades, often in combination with dihydropteroate synthase inhibitors. Resistance to the...

    journal_title:Future microbiology

    pub_type: 杂志文章,评审

    doi:10.2217/17460913.1.1.113

    authors: Yuthavong Y,Kamchonwongpaisan S,Leartsakulpanich U,Chitnumsub P

    更新日期:2006-06-01 00:00:00

166 条记录 5/5 页 « 12345 »